Friday, June 26, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 791 of 1,261
  1. US 8840928

    Tamper-resistant pharmaceutical compositions of opioids and other drugs

    Collegium Pharmaceutical, Inc. · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  2. US 8840905

    Use of neurotoxin therapy for treatment of urologic and related disorders

    The Regents of the University of Colorado · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  3. US 8840886

    Method of treating cancer with DLL4 antagonist and chemotherapeutic agent

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  4. US 8841260

    Methods and compositions for treating Huntington's Disease

    Sangamo Biosciences, Inc. · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  5. US 8840978

    Identification device having antimicrobial properties

    Precision Dynamics Corporation · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  6. US 8841282

    Pyrrolidinone benzenesulfonamide derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  7. US 8841449

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  8. US 8841337

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  9. US 8841408

    Macromonomers and hydrogel systems using native chemical ligation, and their methods of preparation

    Northwestern University · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  10. US 8841350

    Method for inducing UDP-glucuronosyltransferase activity using pterostilbene

    The Regents of the University of California · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  11. US 8841333

    Methods for treating nephrolithiasis

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  12. US 8841308

    Pyrazin-2-amines useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  13. US 8841302

    HCV inhibitor and therapeutic agent combinations

    PTC THERAPEUTICS, INC. · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  14. US 8841288

    Quinolin-4 (1H)-one derivatives as inhibitors of phosphatidylinositol 3-kinases

    UNIVERSITÀ DEGLI STUDI DEL PIEMONTE ORIENTALE “AMEDEO AVOGADRO” · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  15. US 8841295

    5-lipoxygenase-activating protein (FLAP) inhibitors

    Panmira Pharmaceuticals, LLC · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  16. US 8841305

    Activators of the human pyruvate kinase M2 receptor

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  17. US 8840868

    Non-invasive detection of complement-mediated inflammation using CR2-targeted nanoparticles

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  18. US 8841120

    Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity

    Takeda Vaccines, Inc. · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  19. US 8841450

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  20. US 8841483

    Compositions useful as inhibitors of voltage-gated sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  21. US 8841323

    1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors

    Addex Pharma, S.A. · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  22. US 8841258

    Methods to accelerate tissue and wound healing rates and reduce swelling and scar formation

    The Regents of the University of California · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  23. US 2014271836

    MANUFACTURE OF PEANUT FORMULATIONS FOR ORAL DESENSITIZATION

    ALLERGEN RES CORP [US] · Granted Sep 18, 2014 · Expires Sep 13, 2034

    granted
  24. US 2014271721

    PEANUT FORMULATIONS AND USES THEREOF

    ALLERGEN RES CORP [US] · Granted Sep 18, 2014 · Expires Sep 13, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.